## Abstract ## BACKGROUND Hypoxia occurs in association with cancer development, the result being a more aggressive and metastatic cancer phenotype. Hypoxia, which activates hypoxia‐inducible factor‐1 alpha (HIF‐1α), is associated with a number of cellular changes including increased apoptotic res
Tumour-cell apoptosis after cisplat in treatment is not telomere dependent
✍ Scribed by Jessie C. Jeyapalan; Gabriele Saretzki; Alan Leake; Michael J. Tilby; Thomas von Zglinicki
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 934 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cisplatin is a major chemotherapeutic agent, especially for the treatment of neuroblastoma. Telomeres with their sequence (TTAGGG)~n~ are probable targets for cisplatin intrastrand cross‐linking, but the role of telomeres in mediating cisplatin cytotoxicity is not clear. After exposure to cisplatin as single dose or continuous treatment, we found no loss of telomeres in either SHSY5Y neuroblastoma cells (telomere length, ∼4 kbp), HeLa 229 cells (telomere length, 20 kbp) or in the acute lymphoblastic T cell line 1301 (telomere length, ∼80 kbp). There was no induction of telomeric single strand breaks, telomeric overhangs were not degraded and telomerase activity was down‐regulated only after massive onset of apoptosis. In contrast, cisplatin induced a delayed formation of DNA strand breaks and induced DNA damage foci containing γ‐H2A.X at nontelomeric sites. Interstitial DNA damage appears to be more important than telomere loss or telomeric damage as inducer of the signal pathway towards apoptosis and/or growth arrest in cisplatin‐treated tumour cells. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Objective To determine whether treatment with the chimeric anti–tumor necrosis factor α antibody infliximab could reduce cellularity by the induction of apoptosis in synovial tissue. ## Methods Twenty‐four rheumatoid arthritis patients with active disease were randomized to receiv